AR038209A1 - Composicion farmaceutica dispersable oralmente de testosterona - Google Patents

Composicion farmaceutica dispersable oralmente de testosterona

Info

Publication number
AR038209A1
AR038209A1 ARP030100180A ARP030100180A AR038209A1 AR 038209 A1 AR038209 A1 AR 038209A1 AR P030100180 A ARP030100180 A AR P030100180A AR P030100180 A ARP030100180 A AR P030100180A AR 038209 A1 AR038209 A1 AR 038209A1
Authority
AR
Argentina
Prior art keywords
testosterone
pharmaceutical composition
dispersable
orderly
harvested
Prior art date
Application number
ARP030100180A
Other languages
English (en)
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR038209A1 publication Critical patent/AR038209A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composición farmacéutica sólida dispersable oralmente de testosterona que contiene testosterona o uno de sus ésteres farmacéuticamente aceptables, y gránulos que consisten en lactosa y almidón cosecados.
ARP030100180A 2002-01-23 2003-01-22 Composicion farmaceutica dispersable oralmente de testosterona AR038209A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200795A FR2834897B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de testosterone

Publications (1)

Publication Number Publication Date
AR038209A1 true AR038209A1 (es) 2005-01-05

Family

ID=27589559

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100180A AR038209A1 (es) 2002-01-23 2003-01-22 Composicion farmaceutica dispersable oralmente de testosterona

Country Status (3)

Country Link
AR (1) AR038209A1 (es)
FR (1) FR2834897B1 (es)
WO (1) WO2003061664A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2802050T3 (es) * 2012-11-14 2021-01-15 Abon Pharmaceuticals Llc Sistema de administración de fármacos por vía transmucosa oral

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
NZ278678A (en) * 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.

Also Published As

Publication number Publication date
FR2834897A1 (fr) 2003-07-25
FR2834897B1 (fr) 2004-02-27
WO2003061664A1 (fr) 2003-07-31

Similar Documents

Publication Publication Date Title
AR038207A1 (es) Composicion farmaceutica dispersable oralmente de agomelatina
ZA200501677B (en) Hydantoin derivatives and their use as TACE inhibitors.
NO20054369L (no) Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse
BRPI0413363A (pt) formas de dosagem fornecendo liberação controlada de inibidores de proteìna de transferência de ésteres de colesterila e liberação imediata de inibidores de hmg-coa redutase
IL152916A0 (en) Heteroaryl-phenyl heterobicyclic factor xa inhibitors
AP2004003192A0 (en) Combination of azelastine and steroids.
AU2002356759A1 (en) 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
AU2003232241A1 (en) Surgical thread and surgical implant with the same
BR0011172A (pt) Derivados do 4,5-diaril-3(2h)-furanona como inibidores de cliclooxigenase-2
WO2004103311A3 (en) Antibiotic composition
WO2001035950A3 (en) Benzamide therapeutics and methods for treating inflammatory bowel disease
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
YU8302A (sh) Upotreba cgrp-antagonista i cgrp-release-inhibitora za suzbijanje menopauznih toplotnih valunga
MXPA02012160A (es) Composiciones medicinales las cuales contienen derivados de propenona.
NO20044898L (no) Nye etonogestrel estere
MXPA04004372A (es) Derivados heterociclicos de glicinamida y su uso medico.
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
AR038206A1 (es) Composicion farmaceutica dispersable oralmente de ivabradina
AR038305A1 (es) Composicion farmaceutica dispersable oralmente de perindopril
AU2003232115A1 (en) Methods and compositions for the treatment of graft failure
IL197887A0 (en) New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
AR038209A1 (es) Composicion farmaceutica dispersable oralmente de testosterona
HUP0202638A2 (hu) Fermentált búzacsíra-kivonat alkalmazása gyulladáscsökkentő készítmények előállítására
AU2003249930A1 (en) Proteaseome inhibitors for the treatment of herpesviridae infected individuals

Legal Events

Date Code Title Description
FA Abandonment or withdrawal